Palisade Bio (PALI) Receivables - Net (2011 - 2023)
Palisade Bio (PALI) reported Receivables - Net of $300000.0 for Q1 2023, up 408.47% on a QoQ basis from $59000.0 in Q2 2021.
Palisade Bio (PALI) has 12 years of Receivables - Net data on file, last reported at $300000.0 in Q1 2023.
- Quarterly Receivables - Net changed N/A year-over-year to $300000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $300000.0 (changed N/A YoY) and the FY2020 annual result came in at $59000.0, up 180.1% from the prior year.
- Receivables - Net rose to $300000.0 in Q1 2023 per PALI's latest filing, from $59000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $300000.0 in Q1 2023 and bottomed at $8779.0 in Q3 2020.
- The 4-year median for Receivables - Net is $59000.0 (2020), against an average of $88899.5.
- The widest annual swing landed in 2019, when Receivables - Net slumped 92.84%; it then surged 248.33% in 2021.
- Tracing PALI's Receivables - Net over 4 years: stood at $21064.0 in 2019, then jumped by 180.1% to $59000.0 in 2020, then changed by 0.0% to $59000.0 in 2021, then jumped by 408.47% to $300000.0 in 2023.
- Per Business Quant, the three latest PALI Receivables - Net figures stand at $300000.0 (Q1 2023), $59000.0 (Q2 2021), and $25259.0 (Q1 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 300,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Jun 30, 2021 | 59,000.00 |
| Jun 30, 2021 | 59,000.00 |
| Mar 31, 2021 | 25,259.00 |
| Mar 31, 2021 | 25,259.00 |
| Dec 31, 2020 | 59,000.00 |
| Dec 31, 2020 | 59,000.00 |
| Sep 30, 2020 | 8,779.00 |
| Sep 30, 2020 | 8,779.00 |
| Jun 30, 2020 | 16,938.00 |
| Jun 30, 2020 | 16,938.00 |
| Mar 31, 2020 | 19,014.00 |
| Mar 31, 2020 | 19,014.00 |
| Dec 31, 2019 | 21,064.00 |
| Dec 31, 2019 | 21,064.00 |
| Sep 30, 2019 | 61,154.00 |
| Sep 30, 2019 | 61,154.00 |
| Jun 30, 2019 | 169,905.00 |
| Jun 30, 2019 | 169,905.00 |
| Mar 31, 2019 | 237,782.00 |
| Mar 31, 2019 | 237,782.00 |
| Dec 31, 2018 | 294,057.00 |
| Dec 31, 2018 | 294,057.00 |
| Sep 30, 2018 | 161,979.00 |
| Sep 30, 2018 | 161,979.00 |
| Jun 30, 2018 | 478,722.00 |
| Jun 30, 2018 | 478,722.00 |
| Mar 31, 2018 | 137,372.00 |
| Mar 31, 2018 | 137,372.00 |
| Dec 31, 2017 | 312,802.00 |
| Dec 31, 2017 | 312,802.00 |
| Sep 30, 2017 | 37,458.00 |
| Sep 30, 2017 | 37,458.00 |
| Jun 30, 2017 | 5,345.00 |
| Jun 30, 2017 | 5,345.00 |
| Mar 31, 2017 | 14,715.00 |
| Mar 31, 2017 | 14,715.00 |
| Dec 31, 2016 | 10,491.00 |
| Dec 31, 2016 | 10,491.00 |
| Sep 30, 2016 | 12,685.00 |
| Sep 30, 2016 | 12,685.00 |
| Jun 30, 2016 | 5,085.00 |
| Jun 30, 2016 | 5,085.00 |
| Mar 31, 2016 | 39,167.00 |
| Mar 31, 2016 | 39,167.00 |
| Dec 31, 2015 | 37,316.00 |
| Dec 31, 2015 | 37,316.00 |
| Sep 30, 2015 | 19,159.00 |
| Sep 30, 2015 | 19,159.00 |
| Jun 30, 2015 | 18,818.00 |
| Jun 30, 2015 | 18,818.00 |
| Mar 31, 2015 | 8,173.00 |
| Mar 31, 2015 | 8,173.00 |
| Dec 31, 2014 | 225,524.00 |
| Dec 31, 2014 | 225,524.00 |
| Sep 30, 2014 | 32,761.00 |
| Sep 30, 2014 | 32,761.00 |
| Jun 30, 2014 | 24,468.00 |
| Jun 30, 2014 | 24,468.00 |
| Mar 31, 2014 | 11,359.00 |
| Mar 31, 2014 | 11,359.00 |
| Dec 31, 2013 | 10,000.00 |
| Dec 31, 2013 | 10,000.00 |
| Sep 30, 2013 | 7,500.00 |
| Sep 30, 2013 | 7,500.00 |
| Jun 30, 2013 | 56,755.00 |
| Jun 30, 2013 | 56,755.00 |
| Mar 31, 2013 | 104,255.00 |
| Mar 31, 2013 | 104,255.00 |
| Dec 31, 2012 | 3,333.00 |
| Dec 31, 2012 | 3,333.00 |
| Sep 30, 2012 | 833.00 |
| Sep 30, 2012 | 833.00 |
| Jun 30, 2012 | 56,930.00 |
| Jun 30, 2012 | 56,930.00 |
| Mar 31, 2012 | 234,375.00 |
| Mar 31, 2012 | 234,375.00 |
| Dec 31, 2011 | 234,375.00 |
| Dec 31, 2011 | 234,375.00 |